Related Experiment Video
Updated: Apr 16, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Clinical and laboratory characteristics of active and healthy aging (AHA) in octogenarian men
Kirsi K Rantanen1, Timo E Strandberg2,3, Sari S Stenholm4,5,6
1Department of Neurology, Helsinki University Central Hospital and University of Helsinki, P. O. Box 340, 00029 HUCH, Helsinki, Finland. kirsi.rantanen@hus.fi.
Objectives:
To investigate clinical and laboratory variables associated with good subjective and objective health ("active and healthy aging", AHA) in a cohort of octogenarian men.
Design:
Cross-sectional analyses of a longitudinal study.
Setting:
The Helsinki Businessmen Study in Finland.
Participants:
A socioeconomically homogenous cohort of men (baseline n = 3293), born in 1919-1934, has been followed up from the 1960s. From 2000, the men have been regularly sent mailed questionnaires and mortality has been retrieved from national registers.
Measurements:
In 2010 survey, AHA was defined as independently responding to the mailed survey, feeling happy without cognitive or functional impairments and without major diseases. In 2010/11, a random subgroup men was clinically investigated and survivors with healthy and nonhealthy aging were compared.
Results:
By 2010, 1788 men of the baseline cohort had died, and 894 men responded to the mailed survey. 154 (17.2 %) of those fulfilled the present AHA criteria. Increasing number of criteria were negatively (P < 0.001) related to short-term mortality. In 2011, a random sample of 458 men were clinically investigated, 90 of them with AHA. Men with AHA had higher serum LDL cholesterol and diastolic blood pressure (partially explained by less frequent drug use) but no significant difference was observed in other risk factors. Men with AHA had significantly faster walking speed (P < 0.001), stronger handgrip (P = 0.017), better self-rated health and less phenotypic frailty (P = 0.02).
Conclusion:
Less than 5 % enjoyed active and healthy aging over their life course, which was significantly related to markers of frailty but not to the traditional vascular risk factors.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
The Effect of Aging on Tissues
Menopause
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

